Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications
Atherosclerotic cardiovascular diseases (ASCVD) are the major cause of mortality worldwide. Despite the continuous progress in ASCVD therapy, the residual risk persists beyond the management of traditional risk factors. Several infections including <i>Helicobacter pylori</i> infection, p...
Main Authors: | Piotr Szwed, Aleksandra Gąsecka, Mateusz Zawadka, Ceren Eyileten, Marek Postuła, Tomasz Mazurek, Łukasz Szarpak, Krzysztof J. Filipiak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/12/2539 |
Similar Items
-
Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia
by: Piotr Pęczek, et al.
Published: (2021-05-01) -
LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
by: Aleksandra Gąsecka, et al.
Published: (2021-01-01) -
Inclisiran—Silencing the Cholesterol, Speaking up the Prognosis
by: Sylwester Rogula, et al.
Published: (2021-06-01) -
Biomarker-based approach to determine etiology and severity of pulmonary hypertension: Focus on microRNA
by: Sylwester Rogula, et al.
Published: (2022-10-01) -
Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes
by: Aleksandra Gasecka, et al.
Published: (2020-08-01)